EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Blood biomarkers of Alzheimer's disease in the community: Variation by chronic diseases and inflammatory status

Martina Valletta iD, Davide Liborio Vetrano, Debora Rizzuto, Bengt Winblad, Marco Canevelli, Sarah Andersson, Matilda Dale, Claudia Fredolini, Laura Fratiglioni, Giulia Grande

Alzheimer's & Dementia · 2024-06 · 20 (6) · 4115-4125

DOI: 10.1002/alz.13860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 08.05.2024. Verfasst von Martina Valletta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden. Hauptthemen laut MEDLINE: Alzheimer Disease, Biomarkers, Inflammation, Interleukin-6. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Swedish Ministry of Health and Social Affairs, Stiftelsen Sigurd och Elsa Goljes minne.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION We explored the variations of blood biomarkers of Alzheimer's disease (AD) by chronic diseases and systemic inflammation. METHODS We explored the association of AD blood biomarkers with chronic diseases and systemic inflammation (interleukin‐6 [IL‐6]), in 2366 dementia‐free participants of the Swedish National Study on Aging and Care‐in Kungsholmen, using quantile regression models. RESULTS A greater number of co‐occurring chronic diseases was associated with higher concentrations of phosphorylated‐tau 181 (p‐tau181), total‐tau (t‐tau), neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) ( p < 0.01). Anemia, kidney, cerebrovascular, and heart diseases were associated with variations in the levels of AD blood biomarkers. Participants in the highest (vs. lowest) interleukin‐6 (IL‐6) tertile had higher NfL concentration. Systemic inflammation amplified the associations between several chronic diseases and p‐tau181, t‐tau, NfL, and GFAP. DISCUSSION In the community, the concentration of AD blood biomarkers varies in relation to medical conditions and systemic inflammation. Recognizing these influences is crucial for the accurate interpretation and clinical implementation of blood biomarkers. Highlights Participants with a complex clinical profile (i.e., multiple co‐occurring diseases or specific disease combinations) display elevated levels of AD blood‐biomarkers. Anemia, heart, cerebrovascular, and kidney diseases are associated with variations is the levels of AD blood biomarkers in cognitively intact older adults. Systemic inflammation amplifies the association between several chronic diseases and AD blood biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBiomarkersInflammationInterleukin-6tau ProteinsHumansFemaleMaleAgedChronic DiseaseSwedenAged, 80 and overGlial Fibrillary Acidic ProteinNeurofilament Proteins

Stichwörter der Autor:innen

Alzheimer's diseaseblood biomarkerschronic diseasesdementiainflammationpopulation‐based study

Substanzen

BiomarkersInterleukin-6tau Proteinsneurofilament protein LGlial Fibrillary Acidic ProteinNeurofilament Proteins

Autor:innen und Institutionen

  • Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
  • Stockholm Gerontology Research Center, Stockholm, Sweden.
  • Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden.
  • Theme Inflammation and Aging, Karolinska University Hospital, Huddinge, Sweden.
  • Department of Human Neuroscience, Sapienza University, Rome, Italy.
  • National Centre for Disease Prevention and Health Promotion, Italian National Institute of Health, Rome, Italy.

ORCID-Profile: Martina Valletta

Förderung

  • Swedish Research Council
  • Swedish Ministry of Health and Social Affairs
  • Stiftelsen Sigurd och Elsa Goljes minne
  • Hjärnfonden
  • Gamla Tjänarinnor foundation
  • Karolinska Institutet Strategic Research Area in Epidemiology and Biostatistics (SFOEpi)
  • Vetenskapsrådet

Zitieren

APA

Valletta, M., Vetrano, D. L., Rizzuto, D., Winblad, B., Canevelli, M., Andersson, S., Dale, M., Fredolini, C., Fratiglioni, L., & Grande, G. (2024). Blood biomarkers of Alzheimer's disease in the community: Variation by chronic diseases and inflammatory status. Alzheimer's & Dementia, 20(6), 4115-4125. https://doi.org/10.1002/alz.13860

Vancouver

Valletta M, Vetrano DL, Rizzuto D, Winblad B, Canevelli M, Andersson S, et al. Blood biomarkers of Alzheimer's disease in the community: Variation by chronic diseases and inflammatory status. Alzheimer's & Dementia. 2024;20(6):4115-4125. doi:10.1002/alz.13860

BibTeX
@article{Valletta2024,
  author = {Valletta, Martina and Vetrano, Davide Liborio and Rizzuto, Debora and Winblad, Bengt and Canevelli, Marco and Andersson, Sarah and Dale, Matilda and Fredolini, Claudia and Fratiglioni, Laura and Grande, Giulia},
  title = {Blood biomarkers of Alzheimer's disease in the community: Variation by chronic diseases and inflammatory status},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  volume = {20},
  number = {6},
  pages = {4115--4125},
  doi = {10.1002/alz.13860}
}
Kostenlos starten →